Biomarkers in Peripheral Arterial Disease
Authors:
- Ravinder S. VohraRVRavinder S. Vohra
- Sarah BeerSBSarah Beer
- Kashif BhattiKBKashif Bhatti
- Sreenivasan PonnambalamSreenivasan Ponnambalam
- Shervanthi Homer-VanniasinkamSHShervanthi Homer-Vanniasinkam
- 1 July 2009
- journal article
- review article
- Published by Elsevier in Trends in Cardiovascular Medicine
- Vol. 19 (5) , 147-151
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- The effect of intensified lipid-lowering therapy on long-term prognosis in patients with peripheral arterial diseaseJournal of Vascular Surgery, 2007
- N-Terminal Pro-B-Type Natriuretic Peptide, Vascular Disease Risk, and Cholesterol Reduction Among 20,536 Patients in the MRC/BHF Heart Protection StudyJACC, 2007
- Early increases in cardiac troponin levels after major vascular surgery is associated with an increased frequency of delayed cardiac complicationsJournal of Clinical Anesthesia, 2006
- Comparison of Usefulness of Inflammatory Markers in Patients With Versus Without Peripheral Arterial Disease in Predicting Adverse Cardiovascular Outcomes (Myocardial Infarction, Stroke, and Death)The American Journal of Cardiology, 2005
- The Human Plasma ProteomeMolecular & Cellular Proteomics, 2004
- Fibrinogen Predicts Mortality in High Risk Patients with Peripheral Artery DiseaseEuropean Journal of Vascular and Endovascular Surgery, 2003
- Lipoprotein(a) and Coronary Heart DiseaseCirculation, 2000
- Influence of Fibrin Network Conformation and Fibrin Fiber Diameter on Fibrinolysis SpeedArteriosclerosis, Thrombosis, and Vascular Biology, 2000
- Preprocedural serum levels of C-reactive protein predict early complications and late restenosis after coronary angioplastyJACC, 1999
- Mortality over a Period of 10 Years in Patients with Peripheral Arterial DiseaseNew England Journal of Medicine, 1992